| Literature DB >> 21686151 |
Ming-Jie Wu1, Yan Jiang, Yong-Bin Yan.
Abstract
The deficiency of human carbonic anhydrase II (HCAII) has been recognized to be associated with a disease called CAII deficiency syndrome (CADS). Among the many mutations, the P237H mutation has been characterized to lead to a significant decrease in the activity of the enzyme and in the Gibbs free energy of folding. However, sequence alignment indicated that the 237th residue of CAII is not fully conserved across all species. The FoldX theoretical calculations suggested that this residue did not significantly contribute to the overall folding of HCAII, since all mutants had small ΔΔG values (around 1 kcal/mol). The experimental determination indicated that at least three mutations affect HCAII folding significantly and the P237H mutation was the most deleterious one, suggesting that Pro237 was important to HCAII folding. The discrepancy between theoretical and experimental results suggested that caution should be taken when using the prediction methods to evaluate the details of disease-related mutations.Entities:
Keywords: FoldX; carbonic anhydrase II deficiency syndrome (CADS); guanidine hydrochloride-induced unfolding; human carbonic anhydrase II
Mesh:
Substances:
Year: 2011 PMID: 21686151 PMCID: PMC3116157 DOI: 10.3390/ijms12052797
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1.(A) Crystal structure of HCAII (PDB ID 2CBA). Pro237 is highlighted by space-filling model; (B) Sequence alignment of CAII.
Figure 2.The changes in the Gibbs free energy induced by mutations predicted by FoldX.
Relative activity and the thermodynamic parameters of HCAIIpwt and the mutants. ΔG and ΔΔG are presented in kcal/mol, and m is in kcal mol−1 M−1 (GdnHCl). The ΔΔG values were obtained by subtracting the ΔG values of HCAIIpwt from that of the mutants. The activity of the enzymes was normalized by taking HCAIIpwt as 100%.
| HCAIIpwt | 5.7 ± 0.6 | 7.8 ± 0.6 | 13.5 | 0 | 6.3 ± 0.6 | 3.9 ± 0.2 | 100 |
| HCAIIP237A | 6.5 ± 0.7 | 6.0 ± 0.4 | 12.5 | 1.0 | 6.5 ± 0.7 | 2.8 ± 0.2 | 87 |
| HCAIIP237T | 4.7 ± 0.5 | 6.4 ± 0.4 | 11.1 | 2.4 | 5.2 ± 0.6 | 3.0 ± 0.2 | 99 |
| HCAIIP237N | 5.0 ± 0.7 | 7.3 ± 0.5 | 12.3 | 1.2 | 5.5 ± 0.8 | 3.6 ± 0.3 | 93 |
| HCAIIP237I | 5.1 ± 0.5 | 7.5 ± 0.4 | 12.6 | 0.9 | 6.2 ± 0.6 | 3.7 ± 0.2 | 91 |
| HCAIIP237F | 5.3 ± 0.6 | 5.3 ± 0.3 | 10.6 | 2.9 | 6.3 ± 0.7 | 2.5 ± 0.1 | 91 |
| HCAIIP237H | − | − | − | 7.3 | − | − | − |
Figure 3.Far-UV CD spectra of HCAIIpwt and the mutants.
Figure 4.Unfolding transition curves of HCAIIpwt and the mutants monitored by the maximum wavelength of the intrinsic Trp fluorescence. The raw data were fitted by a three-state model and presented as solid lines.
Figure 5.Correlation between the FoldX prediction and the experimental measurements.